J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 84 (2003), 2145-2151; DOI 10.1099/vir.0.19050-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schlereth, B.
Right arrow Articles by Niewiesk, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schlereth, B.
Right arrow Articles by Niewiesk, S.
Agricola
Right arrow Articles by Schlereth, B.
Right arrow Articles by Niewiesk, S.
© 2003 Society for General Microbiology

Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose

Bernd Schlereth1, Linda Buonocore2, Annette Tietz1, Volker ter Meulen1, John K. Rose2 and Stefan Niewiesk1

1 Institute of Virology and Immunobiology, University of Wuerzburg, Versbacher Str. 7, 97078 Wuerzburg, Germany
2 Departments of Pathology, Yale University School of Medicine, 310 Cedar Street, New Haven, CT 06510, USA

Correspondence
Stefan Niewiesk
niewiesk{at}vim.uni-wuerzburg.de

After passive transfer of measles virus (MV)-specific antibodies, vaccine-induced seroconversion and subsequent protection is inhibited in cotton rats (Sigmodon hispidus). In this system, an attenuated, recombinant vesicular stomatitis virus expressing the MV haemagglutinin (VSV-H) was found previously to induce neutralizing antibodies and protection against MV challenge after intranasal (i.n.) immunization. Here it is demonstrated that, after i.n. immunization, VSV-H is found in both lung and brain tissue in the absence of clinical signs. Intratracheal inoculation, which does not lead to infection of the brain, proved that immunization via the lung mucosa is sufficient to protect. To reduce or eliminate infection of the brain after i.n. inoculation, stepwise-attenuated VSV-H mutants with truncated cytoplasmic tails of the G protein were tested in cotton rats. A mutant with 9 aa in the G cytoplasmic tail was found at much lower levels in the brain and was protective in the absence or presence of MV-specific antibodies. A more attenuated mutant containing only 1 aa in its tail was not found in brain tissue after inoculation, but it still induced protective antibody to measles in the absence of MV-specific antibody. However, its ability to induce MV-neutralizing antibodies in the presence of passively transferred MV-specific antibodies and its protective capacity was abolished unless higher-dose immunizations were used. This study demonstrates that a lower degree of attenuation is required to be able to immunize in the presence of MV-specific antibodies.




This article has been cited by other articles:


Home page
J. Virol.Home page
K. Pueschel, A. Tietz, M. Carsillo, M. Steward, and S. Niewiesk
Measles Virus-Specific CD4 T-Cell Activity Does Not Correlate with Protection against Lung Infection or Viral Clearance
J. Virol., August 15, 2007; 81(16): 8571 - 8578.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. D. Simon, J. Publicover, and J. K. Rose
Replication and Propagation of Attenuated Vesicular Stomatitis Virus Vectors In Vivo: Vector Spread Correlates with Induction of Immune Responses and Persistence of Genomic RNA
J. Virol., February 15, 2007; 81(4): 2078 - 2082.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Bukreyev, M. H. Skiadopoulos, B. R. Murphy, and P. L. Collins
Nonsegmented negative-strand viruses as vaccine vectors.
J. Virol., November 1, 2006; 80(21): 10293 - 10306.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2003 by the Society for General Microbiology.